{"name": "Salient Pharmaceuticals",
 "permalink": "salient-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/salient-pharmaceuticals",
 "homepage_url": "http://www.salientpharmaceuticals.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@salientpharmaceuticals.com",
 "phone_number": "(713) 589-9859",
 "description": "",
 "created_at": "Sat Jan 30 04:25:00 UTC 2010",
 "updated_at": "Sat Jan 30 04:25:00 UTC 2010",
 "overview": "\u003Cp\u003ESalient is a Texas-based company formed in 2007 to explore the pharmaceutical application of its proprietary composition of a rare, all-natural mineral. This composition has been proven to adsorb a range of toxins and inflammatory proteins commonly associated with diarrhea.\u003C/p\u003E\n\n\u003Cp\u003ESalient\u00e2\u20ac\u2122s compound, CASAD\u00e2\u201e\u00a2, is envisioned to be a \u00e2\u20ac\u0153platform\u00e2\u20ac\u009d product effective across a spectrum of conditions from Cancer Therapy-Induced Diarrhea to infectious disease and chronic GI conditions. It also has the potential to be used as a rescue agent for other drugs with toxic side effects.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       41],
      "assets/images/resized/0007/5428/75428v1-max-150x150.jpg"],
     [[234,
       65],
      "assets/images/resized/0007/5428/75428v1-max-250x250.jpg"],
     [[234,
       65],
      "assets/images/resized/0007/5428/75428v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Richard",
      "last_name": "M. Scruggs",
      "permalink": "richard-m-scruggs",
      "image": null}},
   {"is_past": false,
    "title": "Chief Science Officer",
    "person":
     {"first_name": "Robert",
      "last_name": "H. Carpenter",
      "permalink": "robert-h-carpenter",
      "image": null}},
   {"is_past": false,
    "title": "board of directors",
    "person":
     {"first_name": "David",
      "last_name": "Steakley",
      "permalink": "david-steakley",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$2M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2010/01/salient-pharmaceuticals-receives-2m.html",
    "source_description": "Salient Pharmaceuticals Receives $2M Funding to Develop Treatment for Cancer Therapy Side Effect",
    "raised_amount": 2000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 1,
    "funded_day": 29,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "The Texas Emerging Technology Fund",
         "permalink": "the-texas-emerging-technology-fund",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0003/0335/30335v2-max-150x150.png"],
             [[250,
               99],
              "assets/images/resized/0003/0335/30335v2-max-250x250.png"],
             [[302,
               120],
              "assets/images/resized/0003/0335/30335v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "5925 Kirby Dr",
    "address2": "Suite E-383",
    "zip_code": "77005",
    "city": "Houston",
    "state_code": "TX",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        78],
       "assets/images/resized/0007/5427/75427v1-max-150x150.jpg"],
      [[250,
        130],
       "assets/images/resized/0007/5427/75427v1-max-250x250.jpg"],
      [[450,
        235],
       "assets/images/resized/0007/5427/75427v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}